Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Rheumatology
•
Systemic lupus erythematosus
•
Dermatology
Do you have concerns about the use of red light therapy in a patient with lupus?
Related Questions
Would you switch azathioprine to a different immunosuppressant if a controlled patient with SLE develops melanoma and/or non-melanoma skin cancer?
What is your approach for severe SCLE in patients unable to tolerate HCQ?
How would you approach management of a patient with longstanding history of SLE, but having active psoriasis?
How would you approach management of a young male patient with discoid lupus who has had minimal response to hydroxychloroquine (and subtherapeutic whole blood levels) who continues to use tobacco products?
What is your approach to practical monitoring of lupus disease activity in clinical practice?
What is your approach to treatment in patients with cutaneous mastocytosis and inflammatory arthritis?
Should patients starting cyclophosphamide be screened routinely for latent tuberculosis (TB)?
How would you manage a patient with severe Hurley Stage 3 active, draining, HS who is also currently requiring Rituxan for management of vasculitis?
How would you approach a young patient with bilateral lower extremity muscle weakness and positive anti-Smith, dsDNA, RNP, Raynaud’s, and pericardial effusion but normal muscle enzymes?
Would you continue belimumab in high risk lupus patients with overlapping scleroderma features with ILD who become pregnant and who are already on HCQ and azathioprine?
